Why Co-Diagnostics Stock Is Crashing Today
Shares of the molecular diagnostic company Co-Diagnostics (NASDAQ: CODX) are getting hammered this morning. The stock is down by 18.3%, as of 10 a.m. EST Tuesday morning.
What's spooking investors today? Ahead of the opening bell, Maxim Group analyst Jason McCarthy downgraded Co-Diagnostics' stock over valuation concerns.
Image source: Getty Images.
Source Fool.com
